Literature DB >> 10782820

Increased expression of interleukin 1alpha and MHC class I in muscle tissue of patients with chronic, inactive polymyositis and dermatomyositis.

P Nyberg1, A L Wikman, I Nennesmo, I Lundberg.   

Abstract

OBJECTIVE: To investigate if there is a molecular correlate in muscle tissue to the persisting decreased muscle function in patients with chronic, inactive polymyositis (PM) and dermatomyositis (DM).
METHODS: Muscle function was assessed using a muscle function index of myositis. To assess disease activity both histopathological investigation of muscle biopsies and magnetic resonance imaging (MRI) scans of the thigh muscles were performed. Inactive chronic disease was defined as persisting muscle weakness and absence of inflammatory infiltrates in muscle biopsy and absence of signs of inflammation on MRI. Expression of interleukin 1alpha (IL-1alpha), IL-1beta,, adhesion molecules, and MHC class I molecules in muscle tissue was investigated with immunohistochemistry.
RESULTS: Muscle weakness was confirmed by a reduction of muscle function score. No signs of inflammation typical for myositis were observed. The most striking finding in our study was the strong expression of IL-1alpha and MHC class I molecules in muscle tissue from patients with inactive chronic PM and DM. Increased IL-1alpha expression was evident in capillaries and increased MHC class I expression was detected in muscle fiber membranes.
CONCLUSION: IL-1alpha and MHC class I molecules may have an importance in the pathogenesis of the chronic muscle weakness and fatigue in patients with PM and DM.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10782820

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  32 in total

1.  Altered cytokine expression of peripheral blood lymphocytes in polymyositis and dermatomyositis.

Authors:  M Aleksza; A Szegedi; P Antal-Szalmás; B Irinyi; L Gergely; A Ponyi; J Hunyadi; S Sipka; M Zeher; G Szegedi; K Dankó
Journal:  Ann Rheum Dis       Date:  2005-04-13       Impact factor: 19.103

Review 2.  Advances in the immunobiology and treatment of inflammatory myopathies.

Authors:  Marinos C Dalakas
Journal:  Curr Rheumatol Rep       Date:  2007-08       Impact factor: 4.592

3.  Limited effects of high-dose intravenous immunoglobulin (IVIG) treatment on molecular expression in muscle tissue of patients with inflammatory myopathies.

Authors:  Sevim Barbasso Helmers; Maryam Dastmalchi; Helene Alexanderson; Inger Nennesmo; Mona Esbjörnsson; Björn Lindvall; Ingrid E Lundberg
Journal:  Ann Rheum Dis       Date:  2007-02-02       Impact factor: 19.103

Review 4.  Secretion without Golgi.

Authors:  Igor Prudovsky; Francesca Tarantini; Matteo Landriscina; David Neivandt; Raffaella Soldi; Aleksandr Kirov; Deena Small; Karuppanan Muthusamy Kathir; Dakshinamurthy Rajalingam; Thallapuranam Krishnaswamy Suresh Kumar
Journal:  J Cell Biochem       Date:  2008-04-01       Impact factor: 4.429

5.  The molecular basis of skeletal muscle weakness in a mouse model of inflammatory myopathy.

Authors:  William Coley; Sree Rayavarapu; Gouri S Pandey; Richard L Sabina; Jack H Van der Meulen; Beryl Ampong; Robert L Wortmann; Rashmi Rawat; Kanneboyina Nagaraju
Journal:  Arthritis Rheum       Date:  2012-11

6.  Idiopathic inflammatory myopathies, signified by distinctive peripheral cytokines, chemokines and the TNF family members B-cell activating factor and a proliferation inducing ligand.

Authors:  Peter Szodoray; Philip Alex; Nicholas Knowlton; Michael Centola; Igor Dozmorov; Istvan Csipo; Annamaria T Nagy; Tamas Constantin; Andrea Ponyi; Britt Nakken; Katalin Danko
Journal:  Rheumatology (Oxford)       Date:  2010-06-29       Impact factor: 7.580

Review 7.  The skeletal muscle arachidonic acid cascade in health and inflammatory disease.

Authors:  Marina Korotkova; Ingrid E Lundberg
Journal:  Nat Rev Rheumatol       Date:  2014-01-28       Impact factor: 20.543

Review 8.  Nonimmune mechanisms of muscle damage in myositis: role of the endoplasmic reticulum stress response and autophagy in the disease pathogenesis.

Authors:  Andrea Henriques-Pons; Kanneboyina Nagaraju
Journal:  Curr Opin Rheumatol       Date:  2009-11       Impact factor: 5.006

9.  Differential immunohistological features of inflammatory myopathies and dysferlinopathy.

Authors:  Jae-Hwan Choi; Yeong-Eun Park; Sung-Il Kim; Jeong-Il Kim; Chang-Hoon Lee; Kyu-Hyun Park; Dae-Seong Kim
Journal:  J Korean Med Sci       Date:  2009-11-07       Impact factor: 2.153

10.  Expression of TLR2, TLR4, and TLR9 in dermatomyositis and polymyositis.

Authors:  Geun-Tae Kim; Mi-La Cho; Young-Eun Park; Wan Hee Yoo; Jung-Hee Kim; Hye-Jwa Oh; Dae-Sung Kim; Seung-Hoon Baek; Sun-Hee Lee; Jun-Hee Lee; Ho-Youn Kim; Sung-Il Kim
Journal:  Clin Rheumatol       Date:  2009-12-02       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.